Genmab Announces Submissions of Regulatory Applications for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL) and Diffuse Large B-Cell Lymphoma (DLBCL)
Edgewise Therapeutics - Jett Foundation Community Webinar: Edgewise Therapeutics – A Novel Approach To Protect Muscle In Duchenne & Becker Muscular Dystrophy